Thermo Fisher Scientific (TMO) Net Equity Issued and Repurchased (2009 - 2014)

Thermo Fisher Scientific (TMO) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $2.9 billion the latest figure, recorded in Q1 2014.

• For the quarter ending Q1 2014, Net Equity Issued and Repurchased changed N/A year-over-year to $2.9 billion; the trailing twelve-month figure through Dec 2014 stood at $2.9 billion (changed N/A YoY), and the FY2017 full-year result was $1.7 billion, changed N/A from the prior year.
• Net Equity Issued and Repurchased rose to $2.9 billion in Q1 2014 per TMO's latest filing, from -$131.3 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $2.9 billion in Q1 2014 and bottomed at -$131.3 million in Q4 2012.
• Historically, Net Equity Issued and Repurchased has averaged $244.4 million across 4 years, with a median of $24.7 million in 2010.
• The widest YoY moves for Net Equity Issued and Repurchased: up 467.23% in 2012, down 3084.09% in 2012.
• Over 4 years, Net Equity Issued and Repurchased stood at $24.7 million in 2010, then slumped by 82.19% to $4.4 million in 2011, then sank by 3084.09% to -$131.3 million in 2012, then soared by 2340.67% to $2.9 billion in 2014.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $2.9 billion, -$131.3 million, and $67.5 million for Q1 2014, Q4 2012, and Q3 2012 respectively.